期刊文献+

Lindsay甲的诊治现状和进展

Diagnosis and Treatment of Lindsay’s Nail: Current Status and Advances
下载PDF
导出
摘要 Lindsay甲是系统性疾病引起的一种甲改变,特征性改变是指甲近端呈白色,甲半月变得不明显,而指甲远端呈红棕色;常见于慢性肾功能不全的患者,也可能与克罗恩病、白塞病、肝硬化等疾病相关;其发病机制目前尚不明确。在已发表的文献中,没有看到白色条带的宽度与肾功能衰竭的严重程度或持续时间、年龄、性别、蛋白尿或其他临床参数之间存在相关性,但可能与局部甲床下毛细血管功能及管腔内红细胞的流动等因素相关,比较重要的有红细胞膜的变形性和血管内皮黏附特性等。甲颜色的改变需要与其他可引起甲变白的多种疾病进行鉴别,特别是临床表现非常接近的Terry甲情况。目前尚未发现特殊的治疗方法,治疗仅针对合并的慢性肾脏疾病等进行。本文将对Lindsay甲的临床表现、发病机制、鉴别诊断、治疗等进行综述,为Lindsay甲的相关研究提供理论参考依据。 Lindsay′s nail is a nail change caused by systemic diseases.The characteristic changes are that the proximal nails are white, the lunula is less obvious, and the distal nails are reddish-brown.It is common in patients with chronic renal insufficiency and may also be associated with Crohn′s disease, Behcet′s disease, liver cirrhosis, and other diseases.The pathogenesis remains unclear.There is no correlation between the width of the white stripe and the severity or duration of renal failure, age, sex, proteinuria or other clinical parameters in the published literature.However, it may be related to the local subnail bed capillary function and the flow of red blood cells in the lumen.The changes in the color of the nail need to be identified from the many other diseases that can cause it to turn white, especially Terry′s nail.At present, the treatment is only for complicated chronic kidney disease.This review summarizes the clinical manifestations, pathogenesis, differential diagnosis, and treatment of Lindsay′s nail and provides a theoretical reference for the research of Lindsay′s nail.
作者 刘昭颖 马寒 LIU Zhaoying;MA Han(Department of Dermatology,the Fifth Affiliated Hospital Sun Yat-sen University,Zhuhai 519000,China)
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2021年第12期1422-1425,共4页 The Chinese Journal of Dermatovenereology
基金 珠海市科技计划医疗卫生项目(ZH2202200003HJL)。
关键词 指(趾)甲疾病 肾功能不全 肝硬化 血液透析 Nail Diseases Renal insufficiency Liver cirrhosis Hemodialysis
  • 相关文献

参考文献4

二级参考文献21

  • 1郭美玲,杨学军,李蕾.老年急性肾衰竭患者182例临床分析[J].中国全科医学,2009,12(7):603-604. 被引量:3
  • 2Arend SM , Mallat MJ , Westendorp R J, et al. Patient survival after renal transplantation : more than 25 years follow- up[J]. Nephrol Dial Transplant, 1997 , 12(8):1672-1679.
  • 3Hariharan S. Case 4 : cardiovascular risk in renal transplantation [ J ]. Transplantation, 2003,75 (9) : 1610-1614.
  • 4Garthwaite EA, Will E J, Bartlett C, et al. Patient-specific prompts in the cholesterol management of renal transplant outpatients : results and analysis of underperformance [ J ]. Transplantation ,2004,78 ( 7 ) : 1042-1047.
  • 5Kasiske BL, Tortorice KL, Heim-Duthoy KL, et al. The adverse impact of cyclosporine on serum lipids in renal transplant recipients [J]. Am J Kidney Dis, 1991, 17 (6) : 700-703.
  • 6Stenvinkel Plnflanunation in end -stage renal disease: the hidden enemy [J]. Nephrology, 2006, 11 (1): 36-41.
  • 7Carrero JJ, Qureshi AR, Axelsson J. Clinical and biochemical implications of low thyroid hormone levels ( total and free forms) in euthyroid patients with chronic kidney disease [ J ]. J Intern Med, 2007, 262 (6) : 690 -701.
  • 8Nagaki M, Naiki T, Brenner DA, et al. Tumor necrosis factor alpha prevents tumor necrosis factor receptormediated mouse hepatocyte apoptosis, but not fasmediated apoptosis: role of nuclear factor-kappaB [J].Hepatology, 2000,32(6):1272-1279.
  • 9Osawa Y, Nagaki M, Banno Y, et al. Tumor necrosis factor alpha-induced interleukin-8 production via NFkappaB and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in human hepatocytes [J]. Infect Immun, 2002,70( 11 ):6294-6301.
  • 10贾永中,曾祥福,魏守顺.肾移植术后血脂的变化对移植肾功能的影响[J].临床泌尿外科杂志,2007,22(10):730-732. 被引量:3

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部